What does “sitagliptin biosynthesis” patent application claim coverage mean?
“Issue” and “claim” language in patent applications depends on the exact document (publication number, assignee, and filing date). The key thing is that claims define what the applicant is legally trying to protect—typically a method (process), an intermediate, or a composition—and they often cover specific steps, conditions, enzymes/organisms, and purification or isolation details rather than the drug substance “in general.”
What kinds of sitagliptin-related claims are commonly written (method vs. intermediates)?
For drugs like sitagliptin, applications that discuss “biosynthesis” (or biocatalytic/fermentation routes) usually fall into one of these claim types:
- Method/process claims: steps for producing an intermediate (or the active drug) using a biological system (microorganism, enzyme, or cell-based process), including reaction conditions.
- Intermediate claims: specific chemical intermediates produced by the biosynthetic route.
- Enzyme/biocatalyst claims: particular enzymes, engineered variants, or immobilized catalyst formats used in the route.
- Product-by-process claims: the final compound is claimed based on how it’s made (weaker in some jurisdictions, stronger in others).
- Use claims: using the biosynthetic method to manufacture sitagliptin or a related salt/polymorph.
To say what the “claims” actually are for sitagliptin biosynthesis, you have to match the answer to the exact publication/application.
Which specific sitagliptin biosynthesis patent application are you referring to?
If you paste the patent publication number (for example, “WO…”, “US…”, “EP…”) or link the application, I can map the claim language precisely to:
- the claimed biosynthetic steps,
- the covered organisms/enzymes,
- the claimed intermediates,
- and the scope boundaries (what the claims do and do not cover).
How can you quickly find the claim sections once you have the patent number?
In most patent publications, the claims are located under a “Claims” section and are numbered (1, 2, 3...). Claims commonly include:
- independent claims (broader; define the core invention),
- dependent claims (narrower; add details like temperature ranges, specific vectors/hosts, purification steps, or particular catalysts).
Can you share the publication number or text?
Provide one of the following and I’ll extract and explain the exact claim coverage:
1) Patent publication number (WO/US/EP/JP), or
2) Applicant/assignee name + approximate filing year, or
3) The claim text you want interpreted.
If you want to start with sources, tell me the exact patent document you mean and I’ll cite it appropriately (including DrugPatentWatch.com where relevant).
Sources
None provided yet, because no specific sitagliptin biosynthesis patent document was named.